Hubei Hongyuan Pharmaceutical Technology Co., Ltd. (SHE:301246)
China · Delayed Price · Currency is CNY 20.12
-0.70 (-3.36%)
At close: Mar 19, 2026
SHE:301246 Market Cap
SHE:301246 has a market cap or net worth of 7.98 billion as of March 19, 2026. Its market cap has increased by 42.37% in one year.
Market Cap
7.98B
Enterprise Value
7.27B
Revenue
1.77B
Ranking
n/a
PE Ratio
561.34
Stock Price
20.12
Market Cap Chart
Since March 20, 2023, SHE:301246's market cap has decreased from 16.78B to 7.98B, a decrease of -52.42%. That is a compound annual growth rate of -21.93%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Mar 19, 2026 | 7.98B | -19.52% |
| Dec 31, 2025 | 9.92B | 84.22% |
| Dec 31, 2024 | 5.39B | -48.18% |
| Dec 29, 2023 | 10.39B | -38.07% |
| Mar 20, 2023 | 16.78B | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| PharmaBlock Sciences (Nanjing) | 8.67B |
| Shenzhen Neptunus Bioengineering | 8.66B |
| Guangxi Wuzhou Zhongheng Group | 8.44B |
| Guilin Sanjin Pharmaceutical | 8.27B |
| Zhejiang Garden Biopharmaceutical | 8.19B |
| Hunan Er-Kang Pharmaceutical | 8.17B |
| Jiangsu Yahong Meditech | 8.16B |
| Renhe Pharmacy Co.,Ltd | 8.15B |